Hansard Adam
Officer at Applied Therapeutics, Inc.
- Sold, on record
- $349k
- Dollars the filings state
- Form 4 sales
- 5
- Latest Mar 14, 2024
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Applied Therapeutics, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Applied Therapeutics, Inc.Plan not statedMay 26, 2021 2021
Sold 2,894 shares at $18.35 ($53k)
Hansard Adam, Chief Commercial Officer
Sold 7.9% of holdings ($669k position)33,570 shares leftFirst sale on recordFiling
- 2 Form 4 sale Applied Therapeutics, Inc.Plan not statedJan 11, 2023 +595 days
Sold 4,495 shares at $0.91 ($4k)
Hansard Adam, Chief Commercial Officer
Sold 4.6% of holdings ($88k position)92,475 shares leftFiling
- 3 Form 4 sale Applied Therapeutics, Inc.No planSep 27, 2023 +259 days
Sold 9,720 shares at $2.70 ($26k)
Hansard Adam, Chief Commercial Officer
No 10b5-1 planSold 2.5% of holdings ($1.1M position)382,755 shares leftFiling
- 4 Form 4 sale Applied Therapeutics, Inc.No planNov 30, 2023 +64 days
Sold 965 shares at $1.97 ($2k)
Hansard Adam, Chief Commercial Officer
No 10b5-1 planSold 0.3% of holdings ($754k position)381,790 shares leftFiling
- 5 Form 4 sale Applied Therapeutics, Inc.UnusualMar 14, 2024 +105 days
Sold 48,871 shares at $5.39 ($263k)
Hansard Adam, Chief Commercial Officer
No 10b5-1 planSold 6.3% of holdings ($4.2M position)732,919 shares left10.9x usual sizeFiling
- 6 Form 144 notice Applied Therapeutics, Inc.NoticeMay 16, 2024 +63 days
Filed to sell 179,425 shares ($754k)
Hansard Adam, Officer
No 10b5-1 plan25.2x usual sizeFiling
- 7 Form 144 notice Applied Therapeutics, Inc.NoticeMay 17, 2024 +1 day
Filed to sell 115,777 shares ($468k)
Hansard Adam, Officer
No 10b5-1 plan16.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (7)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 17, 2024 | May 17, 2024 | Applied Therapeutics, Inc. | Officer | Form 144 notice | 115,777 | $468k | Notice | SEC | |
| May 16, 2024 | May 16, 2024 | Applied Therapeutics, Inc. | Officer | Form 144 notice | 179,425 | $754k | Notice | SEC | |
| Mar 14, 2024 | Mar 18, 2024 | Applied Therapeutics, Inc. | Chief Commercial Officer | Form 4 sale | 48,871 | $263k | 6.3% | Unusual | SEC |
| Nov 30, 2023 | Dec 1, 2023 | Applied Therapeutics, Inc. | Chief Commercial Officer | Form 4 sale | 965 | $2k | 0.3% | No plan | SEC |
| Sep 27, 2023 | Sep 29, 2023 | Applied Therapeutics, Inc. | Chief Commercial Officer | Form 4 sale | 9,720 | $26k | 2.5% | No plan | SEC |
| Jan 11, 2023 | Jan 13, 2023 | Applied Therapeutics, Inc. | Chief Commercial Officer | Form 4 sale | 4,495 | $4k | 4.6% | Plan not stated | SEC |
| May 26, 2021 | May 28, 2021 | Applied Therapeutics, Inc. | Chief Commercial Officer | Form 4 sale | 2,894 | $53k | 7.9% | Plan not stated | SEC |